Literature DB >> 15298484

Refining the measurement of the economic burden of chronic diseases in Canada.

John Rapoport1, Philip Jacobs, Neil R Bell, Scott Klarenbach.   

Abstract

This article presents an analysis of the economic burden of a number of chronic diseases in Canada. In the analysis, we adjusted our measure of utilization of physician and hospital services for co-existing chronic diseases, which we found to be widely prevalent and to have an impact on resource use. Using data from the 1999 National Population Health Survey, we developed resource use rankings for several chronic conditions and decomposed these measures into prevalence and per-person utilization components. Our results indicate that, for the diseases with the greatest impact, resource use measures are driven more by disease prevalence than intensity of resource use. The diseases with the highest overall degree of resource use are back pain, arthritis or rheumatism, high blood pressure and migraines for people under 60; and arthritis or rheumatism and high blood pressure for people over 60. Our methods can be used to forecast the overall relative impact of resource use due to disease prevalence and per-person resource use intensity for various conditions.

Entities:  

Mesh:

Year:  2004        PMID: 15298484

Source DB:  PubMed          Journal:  Chronic Dis Can        ISSN: 0228-8699


  52 in total

1.  Self-efficacy and health locus of control: relationship to occupational disability among workers with back pain.

Authors:  Sylvie Richard; Clermont E Dionne; Arie Nouwen
Journal:  J Occup Rehabil       Date:  2011-09

2.  Arthritis, osteoporosis, and low back pain: evidence-based clinical risk assessment for physical activity and exercise clearance.

Authors:  Jamie Burr; Roy Shephard; Stephen Cornish; Hassanali Vatanparast; Philip Chilibeck
Journal:  Can Fam Physician       Date:  2012-01       Impact factor: 3.275

Review 3.  A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology.

Authors:  Martin Fortin; Moira Stewart; Marie-Eve Poitras; José Almirall; Heather Maddocks
Journal:  Ann Fam Med       Date:  2012 Mar-Apr       Impact factor: 5.166

4.  Prevalence and patterns of chronic disease multimorbidity and associated determinants in Canada.

Authors:  K C Roberts; D P Rao; T L Bennett; L Loukine; G C Jayaraman
Journal:  Health Promot Chronic Dis Prev Can       Date:  2015-08       Impact factor: 3.240

5.  The Canadian minimum dataset for chronic low back pain research: a cross-cultural adaptation of the National Institutes of Health Task Force Research Standards.

Authors:  Anaïs Lacasse; Jean-Sébastien Roy; Alexandre J Parent; Nioushah Noushi; Chúk Odenigbo; Gabrielle Pagé; Nicolas Beaudet; Manon Choinière; Laura S Stone; Mark A Ware
Journal:  CMAJ Open       Date:  2017-03-10

Review 6.  The need for knowledge translation in chronic pain.

Authors:  James L Henry
Journal:  Pain Res Manag       Date:  2008 Nov-Dec       Impact factor: 3.037

Review 7.  In search of analgesia: emerging roles of GPCRs in pain.

Authors:  Laura S Stone; Derek C Molliver
Journal:  Mol Interv       Date:  2009-10

8.  Investigating and predicting early lumbar spine surgery outcomes.

Authors:  Saddam F Kanaan; Paul M Arnold; Douglas C Burton; Hung-Wen Yeh; Lindsay Loyd; Neena K Sharma
Journal:  J Allied Health       Date:  2015

9.  Randomized controlled trials: do they have external validity for patients with multiple comorbidities?

Authors:  Martin Fortin; Jonathan Dionne; Geneviève Pinho; Julie Gignac; José Almirall; Lise Lapointe
Journal:  Ann Fam Med       Date:  2006 Mar-Apr       Impact factor: 5.166

10.  At the interface of community and healthcare systems: a longitudinal cohort study on evolving health and the impact of primary healthcare from the patient's perspective.

Authors:  Jeannie Haggerty; Martin Fortin; Marie-Dominique Beaulieu; Catherine Hudon; Christine Loignon; Michel Préville; Danièle Roberge
Journal:  BMC Health Serv Res       Date:  2010-09-03       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.